Chinese firm Sinovac Biotech is in talks about setting up a production plant in South Africa to supply the African continent with vaccines for a range of diseases, the chief executive of its local partner said on Friday.
Reuters reports that Numolux Group CEO Hilton Klein said:
This clinical trial is a precursor to the establishment of a South African vaccine manufacturing facility partnered by Sinovac and Numolux Group that will cover the entire spectrum of vaccinations beyond just the Covid-19 response.”
We are in talks with Sinovac to set up a vaccine manufacturing facility. A phase one where we will do bottling and labelling so that we can get vaccines out to the people of Africa as soon as possible,” he added. “Vaccines in Africa for Africa.”
Scientists would make swifter progress in solving the world’s problems if they learned to put their egos aside and collaborate better, according to the leading researcher behind the Pfizer/BioNTech Covid vaccine.
“If so many people who are in a certain field would come together in a room and forget their names, their egos, their titles, and just think, they would come up with so many solutions for so many things, but all these titles and whatever get in the way,” Prof Katalin Karikó told the Guardian.Continue reading...